Skip to main content
QMSQMS
QMS
  • Welcome to your QMS
  • Quality Manual
  • Procedures
  • Records
  • Legit.Health Plus Version 1.1.0.0
  • Legit.Health Plus Version 1.1.0.1
  • Legit.Health version 2.1 (Legacy MDD)
  • Legit.Health Utilities
  • Licenses and accreditations
  • Applicable Standards and Regulations
  • BSI Non-Conformities
    • Technical Review
    • Clinical Review
      • Round 1
        • Item 0: Background & Action Plan
        • Item 1: CER Update Frequency
        • Item 2: Device Description & Claims
        • Item 3: Clinical Data
        • Item 4: Usability
        • Item 5: PMS Plan
        • Item 6: PMCF Plan
        • Item 7: Risk
        • MDCG 2020-13 & CER Template (reference)
          • MDCG 2020-13 (CEAR) sections
          • CER Template sections
            • 00 Front matter, introduction, writing tips
            • 1. Administrative particulars
            • 2. Executive summary
            • 3. Scope of the clinical evaluation
            • 4. Clinical evaluation plan — Summary
            • 5. Common specifications and harmonised standards
            • 6. Clinical background, current knowledge, state of the art
            • 7. Equivalence
            • 8. Clinical evidence review
            • 9. Clinical evidence analysis — GSPRs
            • 10. Clinical evidence analysis — Benefit-risk profile
            • 15. Vendor services annex (non-normative)
            • 11–14. Conclusions, Author CVs, References, Excluded sources
        • Adequacy review
        • Coverage matrix
        • task-3b2-3b3-legacy-rwe-study
        • task-3b4-mrmc-dark-phototypes
  • Pricing
  • Public tenders
  • BSI Non-Conformities
  • Clinical Review
  • Round 1
  • MDCG 2020-13 & CER Template (reference)
  • CER Template sections
  • 9. Clinical evidence analysis — GSPRs

9. Clinical evidence analysis — GSPRs

Source: CER Template.pdf pages 21-22 (document: Mantra Systems Free CER Template, Edition 2)

The objective of this section is to draw conclusions as to whether the available clinical evidence demonstrates that the device conforms with the relevant GSPRs, is non-inferior to identified objectives, and is suitable for its intended purpose.

This section should reflect the appraisal of evidence presented above, ensuring that quality evidence is presented and that both favourable and unfavourable data is considered.

9.1. Introduction and methodology​

State an objective for the analysis section (e.g. to analyse suitability of the device for its intended purpose and GSPR conformity).

9.2. Statement on sufficiency of clinical evidence​

Reflect back to requirements on sufficiency of clinical evidence set out in the CEP (and summarised in Section 4 above). Have these requirements been met? Justify conclusions reached.

9.3. GSPR conformity analysis​

9.3.1. GSPR 1 - Requirement on suitability for intended purpose​

Summarise key findings from the clinical evidence relating to the subject device's suitability for its intended purpose. Highlight strengths and weaknesses in the evidence and comment on consistency. Draw an evidence-based conclusion.

9.3.2. GSPR 1 - Requirement on safety and effectiveness and not compromising clinical condition​

Describe to what extent the evidence supports device safety. What parameters have been used? What outcomes have been considered? Provide a justification for conclusions raised.

9.3.3. Performance against safety and performance objectives​

Summarise key findings from the clinical evidence relating to the subject device in terms of quantifiable / qualifiable safety and performance parameters. Compare these with safety & performance outcomes from the SOTA review. The comparison should be statistical, where feasible. Remember - the objective is to demonstrate statistical non-inferiority of the subject device UNLESS the manufacturer makes a specific claim of superiority.

This aspect of writing a CER is complex and requires a detailed understanding of suitable methodology. Contact our team for more information or assistance with comparative analysis.

9.4. GSPR Conformity - Conclusion​

Write a short summary, outlining whether overall GSPR conformity has or has not been demonstrated.

Previous
8. Clinical evidence review
Next
10. Clinical evidence analysis — Benefit-risk profile
  • 9.1. Introduction and methodology
  • 9.2. Statement on sufficiency of clinical evidence
  • 9.3. GSPR conformity analysis
    • 9.3.1. GSPR 1 - Requirement on suitability for intended purpose
    • 9.3.2. GSPR 1 - Requirement on safety and effectiveness and not compromising clinical condition
    • 9.3.3. Performance against safety and performance objectives
  • 9.4. GSPR Conformity - Conclusion
All the information contained in this QMS is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI Labs Group S.L.)